Novel pathogenic variant in haploinsufficiency of A20 with severe gastrointestinal effects and fulminant hepatic failure: A pediatric case series
Year: 2026
Type: article
Study design: Case Report
Abstract: ), encoding a negative regulator of nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) signaling. We report two pediatric patients with a previously unreported novel pathogenic variant (p. Glu409*) in the zinc finger (ZnF) 1 domain, exhibiting markedly divergent phenotypes. Case 1 presented with very-early-onset inflammatory bowel disease (VEO-IBD) and autoimmune thyroiditis, requiring aggressive infliximab dose escalation. Case 2 developed fulminant hepatic failure requiring liver transplantation, followed by post-transplant complications including refractory rejection, recurrent infections, and post-transplant lymphoproliferative disorder. This represents the first known case of HA20 in solid organ transplantation. These cases underscore the importance of early genetic diagnosis in unexplained pediatric inflammatory disease and transplant rejection, as HA20 recognition may alter immunosuppressive strategies and guide therapies including cytokine blockade or Janus kinase (JAK) inhibition.
Source: JPGN Reports
DOI: 10.1002/jpr3.70309
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: A20, haploinsufficiency, novel pathogenic variant, zinc finger, NF-κB signaling, very early onset inflammatory bowel disease, autoimmune thyroiditis, acute liver failure, liver transplantation, post-transplant lymphoproliferative disorder, graft rejection, genetic diagnosis, pediatric inflammatory disease, JAK inhibition
Open Access status: hybrid
Estimated APC paid: $1,900
OpenAlex ID: W7234717365
